- Sputnik International
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

Post-Registration Trials of Russian Vaccine Sputnik V Encouraging, Health Minister Says

© Sputnik / AFK Sistema press service / Go to the mediabankProduction of anti-coronavirus vaccine Sputnik V
Production of anti-coronavirus vaccine Sputnik V - Sputnik International
ST. PETERSBURG (Sputnik) - Post-registration trials of Russian vaccine Sputnik V, which have begun in Belarus as well, are showing encouraging results, Russian Health Minister Mikhail Murashko said.
"The research began with the participation of our colleagues from Belarus. We see that the result we are getting today is encouraging", Murashko told reporters.

In August, the Russian Health Ministry registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Institute, and produced jointly with the Russian Direct Investment Fund. It was named Sputnik V. The vaccine involves the inoculation of two components with an interval of three weeks.

Post-registration clinical trials of the coronavirus vaccine began in Moscow on 7 September, and the first participants were vaccinated on 9 September.

In total, 40,000 volunteers will take part in the study, 10,000 of them will receive a placebo, which is necessary to test the effectiveness of the vaccine.

To participate in the discussion
log in or register
Заголовок открываемого материала